Carbonylative synthesis of 2-(trifluoromethyl)quinazolin-4(3<i>H</i>)-ones from trifluoroacetimidoyl chlorides and amines based on an activated carbon fiber supported palladium catalyst-Reference-Cited by-同舟云学术

Carbonylative synthesis of 2-(trifluoromethyl)quinazolin-4(3H)-ones from trifluoroacetimidoyl chlorides and amines based on an activated carbon fiber supported palladium catalyst

Published:2024 Issue:24 Volume:48 Page:10891-10896
ISSN:1144-0546
Container-title:New Journal of Chemistry
language:en
Short-container-title:New J. Chem.

Author:

Wang Hui¹,Ling Sihao²,Xu Tiefeng³,Chen Zhengkai²^ORCID

Affiliation:

1. Dali College of Women's Wear, Hangzhou Vocational & Technical College, Hangzhou, 310018, China

2. School of Chemistry and Chemical Engineering, Key Laboratory of Surface & Interface Science of Polymer Materials of Zhejiang Province, Zhejiang Sci-Tech University, Hangzhou 310018, China

3. National Engineering Lab for Textile Fiber Materials & Processing Technology (Zhejiang), Zhejiang Sci-Tech University, Hangzhou 310018, China

Abstract

Activated carbon fibers, known for their unique physical and chemical properties, are increasingly utilized in diverse industries, including textiles and fabrics, and can serve as ideal supports of heterogeneous palladium catalysts.

Funder

Natural Science Foundation of Zhejiang Province

Department of Education of Zhejiang Province

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/NJ/D4NJ01278J

Reference59 articles.

1. Synthesis and Anticonvulsant Activity of Acetylenic Quinazolinone Derivatives

2. Antitumor Agents. Part 204: Synthesis and Biological Evaluation of Substituted 2-Aryl Quinazolinones

3. Synthetic approaches, functionalization and therapeutic potential of quinazoline and quinazolinone skeletons: The advances continue

4. Structure–Activity Relationship for the 4(3H)-Quinazolinone Antibacterials

5. Quinazolines and quinazolinones as ubiquitous structural fragments in medicinal chemistry: An update on the development of synthetic methods and pharmacological diversification